Related Experiment Videos
Primary, Secondary, Catastrophic Antiphospholipid Syndrome: is there a difference?
E Nigel Harris1, Silvia S Pierangeli
1Morehouse School of Medicine, 720 Westview Dr SW, Atlanta, GA 30310-1495, USA. harrise@msm.edu
Thrombosis Research
|October 28, 2004
Summary
Antiphospholipid Syndrome (APS) is subcategorized into Primary (PAPS), Secondary (SAPS), and Catastrophic (CAPS). This study explores if these APS subtypes present differently in clinical features, disease course, pathogenesis, or management, questioning the basis for their continued classification.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Antiphospholipid Syndrome (APS) is a recognized autoimmune disorder.
- Current classifications include Primary (PAPS), Secondary (SAPS), and Catastrophic (CAPS) APS.
- The clinical and pathogenetic distinctions between these subtypes are not fully elucidated.
Purpose of the Study:
- To investigate the differences in clinical presentation, disease course, pathogenesis, and management among PAPS, SAPS, and CAPS.
- To evaluate the scientific basis for the continued use of these distinct classifications for APS.
Main Methods:
- Literature review and analysis of existing studies on Antiphospholipid Syndrome subtypes.
- Comparative analysis of clinical data, serological markers, and treatment outcomes across PAPS, SAPS, and CAPS.
Main Results:
- The manuscript aims to present findings on the distinctiveness of APS subtypes.
- Analysis will focus on identifying significant differences or similarities in disease characteristics and progression.
Conclusions:
- The study will conclude on the validity and utility of classifying APS into Primary, Secondary, and Catastrophic forms.
- Recommendations will be made regarding the perpetuation or revision of these classifications in scientific literature and clinical practice.